Bexsero Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

White opalescent liquid suspension.
One dose (0.5 ml) contains: Recombinant Neisseria meningitidis group B NHBA fusion protein ^{1, 2, 3} 50 micrograms; Recombinant Neisseria meningitidis group B NadA protein ^{1, 2, 3} 50 micrograms; Recombinant Neisseria meningitidis group B fHbp fusion protein ^{1, 2, 3} 50 micrograms; Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4 ² 25 micrograms.
¹ produced in E. coli cells by recombinant DNA technology.
² adsorbed on aluminium hydroxide (0.5 mg Al³⁺).
³ NHBA (Neisserial Heparin Binding Antigen), NadA (Neisseria adhesin A), fHbp (factor H binding protein).
Excipients/Inactive Ingredients: Sodium chloride, Histidine, Sucrose, Water for injections.

vaccine, meningococcal

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig